EN
登录

Nature:结肠癌患者CT衍生的身体成分及与年龄、TNM分期和全身炎症的差异相关性

Nature:CT-derived body composition and differential association with age, TNM stage and systemic inflammation in patients with colon cancer

Nature 等信源发布 2024-07-08 20:03

可切换为仅中文


AbstractLow skeletal muscle index/density (SMI/SMD) is prevalent in cancer, adversely prognostic and associated with tumour stage and the systemic inflammatory response (SIR). Age and SMI/SMD has not been widely studied. The present study analyses the association between age and SMI/SMD after adjustment for other clinicopathological factors.

摘要低骨骼肌指数/密度(SMI/SMD)在癌症中普遍存在,预后不良,并与肿瘤分期和全身炎症反应(SIR)相关。年龄和SMI/SMD尚未得到广泛研究。本研究分析了调整其他临床病理因素后年龄与SMI/SMD之间的关系。

Patients undergoing resectional surgery for TNM Stage I-III disease within the West of Scotland between 2011 and 2014 were identified. A single CT slice was obtained from each patients staging CT scan. SMI and SMD were stratified normal/abnormal. The SIR was stratified using Systemic Inflammatory Grade (SIG).

确定了2011年至2014年间在苏格兰西部接受TNM I-III期疾病切除手术的患者。从每个分期CT扫描的患者获得单个CT切片。SMI和SMD分层正常/异常。SIR使用全身炎症分级(SIG)进行分层。

When stratified by age (< 50/50s/60s/70s/80+), 39%/38%/48%/62%/74% and 27%/48%/64%/82%/92% of patients had a low SMI and SMD respectively (both p < 0.001). Older age (OR 1.47, p < 0.001), female sex (OR 1.32, p = 0.032), lower socioeconomic deprivation (OR 1.15, p = 0.004), higher ASA (OR 1.30, p = 0.019), emergency presentation (OR 1.82, p = 0.003), lower BMI (OR 0.67, p < 0.002) and higher SIG (OR 1.23, p < 0.001) were independently associated with low SMI.

当按年龄(50/50/60/70/80+)分层时,分别有39%/38%/48%/62%/74%和27%/48%/64%/82%/92%的患者SMI和SMD较低(均p<0.001)。年龄较大(OR 1.47,p0.001),女性(OR 1.32,p0.032),社会经济剥夺程度较低(OR 1.15,p0.004),ASA较高(OR 1.30,p0.019),急诊(OR 1.82,p0.003),BMI较低(OR 0.67,p0.002),SIG较高(OR 1.23,p<0.001)与低SMI独立相关。

Older age (OR 2.28, p < 0.001), female sex (OR 1.38, p = 0.038), higher ASA (OR 1.92, p < 0.001), emergency presentation (OR 1.71, p = 0.023), and higher SIG (OR 1.37, p < 0.001) were independently associated with lower SMD. Tumour factors were not independently associated with either SMI/SMD. Age was a major factor associated with low SMI/SMD in patients with colon cancer.

年龄较大(OR 2.28,p<0.001),女性(OR 1.38,p<0.038),ASA较高(OR 1.92,p<0.001),紧急情况(OR 1.71,p<0.023)和较高的SIG(OR 1.37,p<0.001)与较低的SMD独立相关。肿瘤因素与SMI/SMD均无独立相关性。年龄是结肠癌患者SMI/SMD低的主要因素。

Therefore, in these patients it is likely that this represents largely constitutional body composition as opposed to being a disease mediated effect. Adjustment for age is required when considering the cancer mediated effect on SMI/SMD in patients with colon cancer..

因此,在这些患者中,这很可能在很大程度上代表了体质成分,而不是疾病介导的作用。考虑到癌症介导的结肠癌患者SMI/SMD的影响时,需要调整年龄。。

IntroductionSarcopenia, coined by Irwin Rosenbeg in 19891 for an age-related reduction in lean muscle mass, until recently, had no widely accepted definition or diagnostic criteria. In 2009 (and subsequently updated in 20192, the Sarcopenia Working Group defined sarcopenia as “progressive and generalized loss of skeletal muscle mass and strength” that may be primary (aging) or secondary (including disease, nutrition or activity related).

引言肌肉减少症,由欧文·罗森贝格(IrwinRosenbeg)于19891年创造,用于与年龄相关的瘦肌肉质量减少,直到最近,还没有被广泛接受的定义或诊断标准。2009年(随后于20192年更新),肌肉减少症工作组将肌肉减少症定义为“进行性和全身性骨骼肌质量和力量丧失”,可能是原发性(衰老)或继发性(包括疾病,营养或活动相关)。

Low muscle mass combined with impairment of muscle function, has been recognized for decades however was only defined as an independent disease entity within the ICD-10 classification in 20163. This has corresponded with an increased research output around body composition, in particular low skeletal muscle mass/strength (sarcopenia) and low skeletal muscle density within a number of areas of clinical practice, including cancer.Multiple modalities of stratifying body composition including dual energy x-ray absorptiometry (DXA), computed tomography (CT) and magnetic resonance imaging (MRI) techniques have been described4.

几十年来,人们已经认识到低肌肉质量与肌肉功能受损相结合,但仅在20163年的ICD-10分类中被定义为独立的疾病实体。这与围绕身体成分的研究成果增加相对应,特别是在包括癌症在内的许多临床实践领域内,骨骼肌质量/强度低(肌肉减少症)和骨骼肌密度低。已经描述了多种分层身体成分的方式,包括双能x射线吸收测定法(DXA),计算机断层扫描(CT)和磁共振成像(MRI)技术4。

Within oncology, the use of CT imaging for stratification of skeletal muscle mass/density dominates the literature, due to the widespread availability of CT imaging routinely carried out for cancer staging5. Predominantly, a single CT slice obtained at the level of the third lumbar vertebrae is analyzed with muscle area and density being stratified as previously described by Martin and colleagues6.

在肿瘤学中,由于常规用于癌症分期的CT成像的广泛可用性,使用CT成像对骨骼肌质量/密度进行分层在文献中占主导地位5。主要是,如Martin及其同事先前所述,分析在第三腰椎水平获得的单个CT切片,并对肌肉面积和密度进行分层6。

Low skeletal muscle mass (based on CT image analysis) is typically used as a surrogate for sarcopenia.In patients with cancer, low skeletal muscle mass has been reported to be highly prevalent. A recent meta-analysis by Surov and colleagues7 including approximately 80,000 patients with solid organ tumours reported an overall .

低骨骼肌质量(基于CT图像分析)通常用作肌肉减少症的替代指标。据报道,在癌症患者中,低骨骼肌质量非常普遍。Surov及其同事最近进行的一项荟萃分析[7]包括约80000例实体器官肿瘤患者,总体报告。

Data availability

数据可用性

Data is available on request. The corresponding author (Allan Golder) should be contacted for such requests.

数据可根据要求提供。应联系通讯作者(Allan Golder)以获取此类请求。

ReferencesRosenberg, I. H. Summary comments. Am. J. Clin. Nutr. 50(5), 1231–1233 (1989).Article

参考Rosenberg,I.H。摘要评论。美国J.克林。营养。50(5),1231-1233(1989)。文章

Google Scholar

谷歌学者

Cruz-Jentoft, A. J. et al. Sarcopenia: Revised European consensus on definition and diagnosis. Age Ageing. 48(1), 16–31 (2019).Article

Cruz-Jentoft,A.J.等人,《肌肉减少症:修订的欧洲定义和诊断共识》。年龄老化。48(1),16-31(2019)。文章

PubMed

PubMed

Google Scholar

谷歌学者

Anker, S. D., Morley, J. E. & von Haehling, S. Welcome to the ICD-10 code for sarcopenia. J. Cachexia Sarcopenia Muscle. 7(5), 512–514 (2016).Article

Anker,S.D.,Morley,J.E。和von Haehling,S。欢迎使用肌肉减少症的ICD-10代码。J、 恶病质肌肉减少症。7(5),512-514(2016)。文章

PubMed

PubMed

PubMed Central

公共医学中心

Google Scholar

谷歌学者

Albano, D., Messina, C., Vitale, J. & Sconfienza, L. M. Imaging of sarcopenia: Old evidence and new insights. Eur. Radiol. 30(4), 2199–2208 (2020).Article

Albano,D.,Messina,C.,Vitale,J.&Sconfienza,L.M。肌肉减少症的成像:旧证据和新见解。欧洲放射性。30(4),2199-2208(2020)。文章

PubMed

PubMed

Google Scholar

谷歌学者

Shen, W. et al. Total body skeletal muscle and adipose tissue volumes: Estimation from a single abdominal cross-sectional image. J. Appl. Physiol. (1985) 97(6), 2333–2338 (2004).Article

Shen,W。等人。全身骨骼肌和脂肪组织体积:从单个腹部横截面图像估计。J、 应用。生理学。(1985)97(6),2333-2338(2004)。文章

PubMed

PubMed

Google Scholar

谷歌学者

Martin, L. et al. Cancer cachexia in the age of obesity: Skeletal muscle depletion is a powerful prognostic factor, independent of body mass index. J. Clin. Oncol. 31(12), 1539–1547 (2013).Article

Martin,L.等人,《肥胖年龄的癌症恶病质:骨骼肌耗竭是一个强有力的预后因素,与体重指数无关。J、 临床。Oncol公司。31(12),1539-1547(2013)。文章

PubMed

PubMed

Google Scholar

谷歌学者

Surov, A. & Wienke, A. Prevalence of sarcopenia in patients with solid tumors: A meta-analysis based on 81,814 patients. JPEN J. Parenter. Enteral Nutr. 46(8), 1761–1768 (2022).Article

Surov,A。&Wienke,A。实体瘤患者肌肉减少症的患病率:基于81814名患者的荟萃分析。JPEN J.Parenter。肠内营养。46(8),1761-1768(2022)。文章

CAS

中科院

PubMed

PubMed

Google Scholar

谷歌学者

McGovern, J., Dolan, R. D., Horgan, P. G., Laird, B. J. & McMillan, D. C. Computed tomography-defined low skeletal muscle index and density in cancer patients: Observations from a systematic review. J. Cachexia Sarcopenia Muscle. 12, 1408–1417 (2021).Article

McGovern,J.,Dolan,R.D.,Horgan,P.G.,Laird,B.J。&McMillan,D.C。计算机断层扫描定义了癌症患者的低骨骼肌指数和密度:系统评价的观察结果。J、 恶病质肌肉减少症。121408-1417(2021)。文章

PubMed

PubMed

PubMed Central

公共医学中心

Google Scholar

谷歌学者

Dolan, R. D. et al. The relationship between computed tomography-derived body composition, systemic inflammatory response, and survival in patients undergoing surgery for colorectal cancer. J. Cachexia Sarcopenia Muscle. 10(1), 111–122 (2019).Article

Dolan,R.D.等人。计算机断层扫描衍生的身体成分,全身炎症反应与接受结直肠癌手术的患者生存之间的关系。J、 恶病质肌肉减少症。10(1),111-122(2019)。文章

PubMed

PubMed

Google Scholar

谷歌学者

Pamoukdjian, F. et al. Prevalence and predictive value of pre-therapeutic sarcopenia in cancer patients: A systematic review. Clin. Nutr. 37(4), 1101–1113 (2018).Article

Pamoukdjian,F。等人。癌症患者治疗前肌肉减少症的患病率和预测价值:系统评价。临床。营养。37(4),1101-1113(2018)。文章

PubMed

PubMed

Google Scholar

谷歌学者

Sun, Q. et al. Sarcopenia among older patients with cancer: A scoping review of the literature. J. Geriatr. Oncol. 13(7), 924–934 (2022).Article

Sun,Q.等人,《老年癌症患者的肌肉减少症:文献范围综述》。J、 老年人。Oncol公司。13(7),924-934(2022)。文章

CAS

中科院

PubMed

PubMed

Google Scholar

谷歌学者

Hopkins, J. J. et al. The impact of muscle and adipose tissue on long-term survival in patients with stage I to III colorectal cancer. Dis. Colon Rectum. 62(5), 549–560 (2019).Article

Hopkins,J.J.等人,《肌肉和脂肪组织对I至III期结直肠癌患者长期生存的影响》。Dis。结肠直肠。62(5),549-560(2019)。文章

PubMed

PubMed

Google Scholar

谷歌学者

Shachar, S. S., Williams, G. R., Muss, H. B. & Nishijima, T. F. Prognostic value of sarcopenia in adults with solid tumours: A meta-analysis and systematic review. Eur. J. Cancer. 57, 58–67 (2016).Article

Shachar,S.S.,Williams,G.R.,Muss,H.B。&Nishijima,T.F。肌肉减少症在实体瘤成人中的预后价值:荟萃分析和系统评价。Eur.J.癌症。57,58-67(2016)。文章

PubMed

PubMed

Google Scholar

谷歌学者

Xiao, J. et al. The association of medical and demographic characteristics with sarcopenia and low muscle radiodensity in patients with nonmetastatic colorectal cancer. Am. J. Clin. Nutr. 109(3), 615–625 (2019).Article

Xiao,J.等人。非转移性结直肠癌患者的医学和人口统计学特征与肌肉减少症和低肌肉放射密度的关系。美国J.克林。营养。109(3),615-625(2019)。文章

PubMed

PubMed

PubMed Central

公共医学中心

Google Scholar

谷歌学者

Drami, I. et al. Body composition and dose-limiting toxicity in colorectal cancer chemotherapy treatment; a systematic review of the literature. Could muscle mass be the new body surface area in chemotherapy dosing?. Clin. Oncol. (R. Coll. Radiol.) 33(12), e540–e552 (2021).Article

Drami,I。等人。结直肠癌化疗治疗中的身体成分和剂量限制性毒性;文献的系统综述。肌肉质量可能是化疗剂量中新的体表面积吗?。临床。Oncol公司。(R.Coll.Radiol。)33(12),e540–e552(2021)。文章

CAS

中科院

PubMed

PubMed

Google Scholar

谷歌学者

Hilmi, M. et al. Body composition and sarcopenia: The next-generation of personalized oncology and pharmacology?. Pharmacol. Ther. 196, 135–159 (2019).Article

Hilmi,M.等人,《身体成分和肌肉减少症:下一代个性化肿瘤学和药理学?》?。药理学。他们。196135-159(2019)。文章

CAS

中科院

PubMed

PubMed

Google Scholar

谷歌学者

Cederholm, T. et al. GLIM criteria for the diagnosis of malnutrition—A consensus report from the global clinical nutrition community. Clin. Nutr. 38(1), 1–9 (2019).Article

Cederholm,T.等人,《GLIM营养不良诊断标准——全球临床营养界的共识报告》。临床。营养。38(1),1-9(2019)。文章

CAS

中科院

PubMed

PubMed

Google Scholar

谷歌学者

Pring, E. T. et al. Tumour grade and stage are associated with specific body composition phenotypes with visceral obesity predisposing the host to a less aggressive tumour in colorectal cancer. Eur. J. Surg. Oncol. 48(7), 1664–1670 (2022).Article

Spring,E.T。等人。肿瘤分级和分期与特定的身体成分表型有关,内脏肥胖使宿主易患结直肠癌侵袭性较低的肿瘤。欧洲外科肿瘤学杂志。48(7),1664-1670(2022)。文章

PubMed

PubMed

Google Scholar

谷歌学者

McSorley, S. T., Black, D. H., Horgan, P. G. & McMillan, D. C. The relationship between tumour stage, systemic inflammation, body composition and survival in patients with colorectal cancer. Clin. Nutr. 37(4), 1279–1285 (2018).Article

McSorley,S.T.,Black,D.H.,Horgan,P.G。&McMillan,D.C。结直肠癌患者肿瘤分期,全身炎症,身体成分与生存率之间的关系。临床。营养。37(4),1279-1285(2018)。文章

PubMed

PubMed

Google Scholar

谷歌学者

Kroenke, C. H. et al. Muscle radiodensity and mortality in patients with colorectal cancer. Cancer. 124(14), 3008–3015 (2018).Article

Kroenke,C.H.等人,《结直肠癌患者的肌肉放射密度和死亡率》。癌症。124(14),3008-3015(2018)。文章

PubMed

PubMed

Google Scholar

谷歌学者

Golder, A. M. et al. The relationship between the mode of presentation, CT-derived body composition, systemic inflammatory grade and survival in colon cancer. J. Cachexia Sarcopenia Muscle. 13(6), 2863–2874 (2022).Article

Golder,A.M.等人。结肠癌的表现方式,CT衍生的身体成分,全身炎症程度与生存率之间的关系。J、 恶病质肌肉减少症。13(6),2863–2874(2022)。文章

PubMed

PubMed

PubMed Central

公共医学中心

Google Scholar

谷歌学者

Abbass, T., Dolan, R. D., Laird, B. J. & McMillan, D. C. The relationship between imaging-based body composition analysis and the systemic inflammatory response in patients with cancer: A systematic review. Cancers 11(9), 1304 (2019).Article

Abbass,T.,Dolan,R.D.,Laird,B.J。&McMillan,D.C。基于成像的身体成分分析与癌症患者全身炎症反应之间的关系:系统综述。癌症11(9),1304(2019)。文章

CAS

中科院

PubMed

PubMed

PubMed Central

公共医学中心

Google Scholar

谷歌学者

Black, D. et al. Prognostic value of computed tomography: Measured parameters of body composition in primary operable gastrointestinal cancers. Ann. Surg. Oncol. 24(8), 2241–2251 (2017).Article

Black,D。等人。计算机断层扫描的预后价值:原发性可手术胃肠道癌症中身体成分的测量参数。安。外科。Oncol。24(8),2241-2251(2017)。文章

PubMed

PubMed

PubMed Central

公共医学中心

Google Scholar

谷歌学者

Metter, E. J., Conwit, R., Tobin, J. & Fozard, J. L. Age-associated loss of power and strength in the upper extremities in women and men. J. Gerontol. A Biol. Sci. Med. Sci. 52(5), B267–B276 (1997).Article

Metter,E.J.,Conwit,R.,Tobin,J。&Fozard,J.L。与年龄相关的女性和男性上肢力量和力量的丧失。J、 Gerontol公司。生物科学。医学科学。52(5),B267–B276(1997)。文章

CAS

中科院

PubMed

PubMed

Google Scholar

谷歌学者

Dolan, R. D. et al. The relationship between ECOG-PS, mGPS, BMI/WL grade and body composition and physical function in patients with advanced cancer. Cancers. 12(5), 1187 (2020).Article

Dolan,R.D.等人。晚期癌症患者ECOG-PS,mGPS,BMI/WL分级与身体成分和身体机能之间的关系。癌症。12(5),1187(2020)。文章

CAS

中科院

PubMed

PubMed

PubMed Central

公共医学中心

Google Scholar

谷歌学者

Golder, A. M. et al. The prognostic value of combined measures of the systemic inflammatory response in patients with colon cancer: An analysis of 1700 patients. Br. J. Cancer. 124, 1828–1835 (2021).Article

Golder,A.M.等人。结肠癌患者全身炎症反应综合测量的预后价值:对1700名患者的分析。Br.J.癌症。1241828-1835(2021)。文章

CAS

中科院

PubMed

PubMed

PubMed Central

公共医学中心

Google Scholar

谷歌学者

Brewster, D., Muir, C. & Crichton, J. Registration of colorectal cancer in Scotland: An assessment of data accuracy based on review of medical records. Public Health. 109(4), 285–292 (1995).Article

Brewster,D.,Muir,C。&Crichton,J。苏格兰结直肠癌登记:基于病历审查的数据准确性评估。公共卫生。109(4),285-292(1995)。文章

CAS

中科院

PubMed

PubMed

Google Scholar

谷歌学者

Brewster, D. H., Stockton, D., Harvey, J. & Mackay, M. Reliability of cancer registration data in Scotland, 1997. Eur. J. Cancer. 38(3), 414–417 (2002).Article

Brewster,D.H.,Stockton,D.,Harvey,J.&Mackay,M。苏格兰癌症登记数据的可靠性,1997年。Eur.J.癌症。38(3),414-417(2002)。文章

CAS

中科院

PubMed

PubMed

Google Scholar

谷歌学者

Ralston, K., Dundas, R. & Leyland, A. H. A comparison of the Scottish Index of Multiple Deprivation (SIMD) 2004 with the 2009 + 1 SIMD: Does choice of measure affect the interpretation of inequality in mortality?. Int. J. Health Geogr. 13, 27 (2014).Article

Ralston,K.,Dundas,R。&Leyland,A.H。2004年苏格兰多重剥夺指数(SIMD)与2009年+1 SIMD的比较:措施的选择是否会影响死亡率不平等的解释?。国际卫生地理杂志。13,27(2014)。文章

PubMed

PubMed

PubMed Central

公共医学中心

Google Scholar

谷歌学者

Mourtzakis, M. et al. A practical and precise approach to quantification of body composition in cancer patients using computed tomography images acquired during routine care. Appl. Physiol. Nutr. Metab. 33(5), 997–1006 (2008).Article

Mourtzakis,M.等人。使用常规护理期间获得的计算机断层扫描图像对癌症患者身体成分进行定量的实用而精确的方法。应用。生理学。营养。代谢。33(5),997–1006(2008)。文章

PubMed

PubMed

Google Scholar

谷歌学者

Dolan, R. D., Tien, Y.-T., Horgan, P. G., Edwards, C. A. & McMillan, D. C. The relationship between computed tomography-derived body composition and survival in colorectal cancer: The effect of image software. JCSM Rapid Commun. 3(2), 81–90 (2020).Article

Dolan,R.D.,Tien,Y.-T.,Horgan,P.G.,Edwards,C.A。&McMillan,D.C。计算机断层扫描衍生的身体成分与结直肠癌生存之间的关系:图像软件的影响。JCSM快速通信。3(2),81-90(2020)。文章

Google Scholar

谷歌学者

Ebadi, M. et al. Subcutaneous adiposity is an independent predictor of mortality in cancer patients. Br. J. Cancer. 117(1), 148–155 (2017).Article

皮下肥胖是癌症患者死亡率的独立预测因子。Br.J.癌症。117(1),148-155(2017)。文章

PubMed

PubMed

PubMed Central

公共医学中心

Google Scholar

谷歌学者

Doyle, S. L. et al. Establishing computed tomography-defined visceral fat area thresholds for use in obesity-related cancer research. Nutr. Res. 33(3), 171–179 (2013).Article

Doyle,S.L.等人建立计算机断层扫描定义的内脏脂肪面积阈值,用于肥胖相关的癌症研究。营养。第33(3)号决议,第171-179(2013)号决议。文章

CAS

中科院

PubMed

PubMed

Google Scholar

谷歌学者

Cruz-Jentoft, A. J. et al. Sarcopenia: European consensus on definition and diagnosis: Report of the European Working Group on Sarcopenia in Older People. Age Ageing. 39(4), 412–423 (2010).Article

Cruz Jentoft,A.J.等人,《肌肉减少症:欧洲关于定义和诊断的共识:欧洲老年人肌肉减少症工作组的报告》。年龄老化。39(4),412-423(2010)。文章

PubMed

PubMed

PubMed Central

公共医学中心

Google Scholar

谷歌学者

Goodpaster, B. H., Kelley, D. E., Thaete, F. L., He, J. & Ross, R. Skeletal muscle attenuation determined by computed tomography is associated with skeletal muscle lipid content. J. Appl. Physiol. (1985) 89(1), 104–110 (2000).Article

Goodpaster,B.H.,Kelley,D.E.,Thaete,F.L.,He,J。&Ross,R。通过计算机断层扫描确定的骨骼肌衰减与骨骼肌脂质含量有关。J、 应用。生理学。(1985)89(1),104-110(2000)。文章

CAS

中科院

PubMed

PubMed

Google Scholar

谷歌学者

Klassen, P. N., Mazurak, V. C., Thorlakson, J. & Servais, S. Call for standardization in assessment and reporting of muscle and adipose change using computed tomography analysis in oncology: A scoping review. J. Cachexia Sarcopenia Muscle. 14(5), 1918–1931 (2023).Article

Klassen,P.N.,Mazurak,V.C.,Thorlakson,J。&Servais,S。呼吁在肿瘤学中使用计算机断层扫描分析评估和报告肌肉和脂肪变化的标准化:范围界定评论。J、 恶病质肌肉减少症。14(5),1918-1931(2023)。文章

PubMed

PubMed

PubMed Central

公共医学中心

Google Scholar

谷歌学者

Mayhew, A. J. et al. The prevalence of sarcopenia in community-dwelling older adults, an exploration of differences between studies and within definitions: A systematic review and meta-analyses. Age Ageing. 48(1), 48–56 (2019).Article

Mayhew,A.J.等人,《社区老年人肌肉减少症的患病率,研究之间和定义内差异的探索:系统综述和荟萃分析》。年龄老化。48(1),48-56(2019)。文章

CAS

中科院

PubMed

PubMed

Google Scholar

谷歌学者

Papadopoulou, S. K. Sarcopenia: A contemporary health problem among older adult populations. Nutrients. 12(5), 1293 (2020).Article

Papadopoulou,S.K。肌肉减少症:老年人群中的当代健康问题。营养素。12(5),1293(2020)。文章

PubMed

PubMed

PubMed Central

公共医学中心

Google Scholar

谷歌学者

Malietzis, G. et al. The role of body composition evaluation by computerized tomography in determining colorectal cancer treatment outcomes: A systematic review. Eur. J. Surg. Oncol. 41(2), 186–196 (2015).Article

Malietzis,G。等人。通过计算机断层扫描评估身体成分在确定结直肠癌治疗结果中的作用:系统评价。欧洲外科肿瘤学杂志。41(2),186-196(2015)。文章

CAS

中科院

PubMed

PubMed

Google Scholar

谷歌学者

Martin, L. et al. Diagnostic criteria for cancer cachexia: Reduced food intake and inflammation predict weight loss and survival in an international, multi-cohort analysis. J. Cachexia Sarcopenia Muscle. 12(5), 1189–1202 (2021).Article

Martin,L.等人。癌症恶病质的诊断标准:在国际多队列分析中,减少食物摄入和炎症可预测体重减轻和生存。J、 恶病质肌肉减少症。12(5),1189-1202(2021)。文章

PubMed

PubMed

PubMed Central

公共医学中心

Google Scholar

谷歌学者

Magudia, K. et al. Population-scale CT-based body composition analysis of a large outpatient population using deep learning to derive age-, sex-, and race-specific reference curves. Radiology. 298(2), 319–329 (2021).Article

Magudia,K.等人。基于人群规模CT的大型门诊人群身体成分分析,使用深度学习得出年龄,性别和种族特定的参考曲线。放射学。298(2),319-329(2021)。文章

PubMed

PubMed

Google Scholar

谷歌学者

UK CR. https://www.cancerresearchuk.org/health-professional/cancer-statistics/statistics-by-cancer-type/bowel-cancer#heading-Two (2021).Prado, C. M. et al. Prevalence and clinical implications of sarcopenic obesity in patients with solid tumours of the respiratory and gastrointestinal tracts: A population-based study.

英国CR。https://www.cancerresearchuk.org/health-professional/cancer-statistics/statistics-by-cancer-type/bowel-cancer#heading-两(2021)。Prado,C.M.等人。呼吸道和胃肠道实体瘤患者肌肉减少性肥胖的患病率和临床意义:一项基于人群的研究。

Lancet Oncol. 9(7), 629–635 (2008).Article .

柳叶刀Oncol。9(7),629-635(2008)。文章。

PubMed

PubMed

Google Scholar

谷歌学者

Cespedes Feliciano, E. M. et al. Muscle mass at the time of diagnosis of nonmetastatic colon cancer and early discontinuation of chemotherapy, delays, and dose reductions on adjuvant FOLFOX: The C-SCANS study. Cancer. 123(24), 4868–4877 (2017).Article

Cespedes Feliciano,E.M.等人,《非转移性结肠癌诊断时的肌肉质量以及早期停止化疗、延迟和减少辅助FOLFOX的剂量:C扫描研究》。癌症。123(24),4868–4877(2017)。文章

CAS

中科院

PubMed

PubMed

Google Scholar

谷歌学者

Gerard, S. et al. Body composition and anti-neoplastic treatment in adult and older subjects—A systematic review. J. Nutr. Health Aging. 20(8), 878–888 (2016).Article

Gerard,S.等人,《成人和老年受试者的身体成分和抗肿瘤治疗-系统综述》。J、 营养。健康老龄化。20(8),878-888(2016)。文章

CAS

中科院

PubMed

PubMed

Google Scholar

谷歌学者

Prasanna, T., Beith, J., Kao, S., Boyer, M. & McNeil, C. M. Dose modifications in adjuvant chemotherapy for solid organ malignancies: A systematic review of clinical trials. Asia Pac. J. Clin. Oncol. 14(3), 125–133 (2018).Article

Prasanna,T.,Beith,J.,Kao,S.,Boyer,M。&McNeil,C.M。实体器官恶性肿瘤辅助化疗的剂量调整:临床试验的系统评价。亚太地区。J、 临床。Oncol公司。14(3),125-133(2018)。文章

PubMed

PubMed

Google Scholar

谷歌学者

Lewis, J. H. et al. Participation of patients 65 years of age or older in cancer clinical trials. J. Clin. Oncol. 21(7), 1383–1389 (2003).Article

Lewis,J.H.等人。65岁或以上患者参与癌症临床试验。J、 临床。Oncol公司。21(7),1383-1389(2003)。文章

PubMed

PubMed

Google Scholar

谷歌学者

Sud, S., Lai, P., Zhang, T., Clemons, M. & Wheatley-Price, P. Chemotherapy in the oldest old: The feasibility of delivering cytotoxic therapy to patients 80 years old and older. J. Geriatr. Oncol. 6(5), 395–400 (2015).Article

Sud,S.,Lai,P.,Zhang,T.,Clemons,M。&Wheatley-Price,P。高龄患者的化疗:向80岁及以上患者提供细胞毒性治疗的可行性。J、 老年人。Oncol公司。6(5),395-400(2015)。文章

PubMed

PubMed

Google Scholar

谷歌学者

Reif de Paula, T., Simon, H. L., Profeta da Luz, M. M. & Keller, D. S. Right sided colorectal cancer increases with age and screening should be tailored to reflect this: A national cancer database study. Tech. Coloproctol. 25(1), 81–89 (2021).Article

Reif de Paula,T.,Simon,H.L.,Profeta da Luz,M.M。&Keller,D.S。右侧结直肠癌随着年龄的增长而增加,筛查应该适应这一点:国家癌症数据库研究。科洛普托尔技术公司。25(1),81-89(2021)。文章

CAS

中科院

PubMed

PubMed

Google Scholar

谷歌学者

Patel, M. et al. The relationship between right-sided tumour location, tumour microenvironment, systemic inflammation, adjuvant therapy and survival in patients undergoing surgery for colon and rectal cancer. Br. J. Cancer. 118(5), 705–712 (2018).Article

Patel,M.等人。结肠癌和直肠癌手术患者右侧肿瘤位置,肿瘤微环境,全身炎症,辅助治疗与生存之间的关系。Br.J.癌症。118(5),705-712(2018)。文章

PubMed

PubMed

PubMed Central

公共医学中心

Google Scholar

谷歌学者

Saltzstein, S. L. & Behling, C. A. Age and time as factors in the left-to-right shift of the subsite of colorectal adenocarcinoma: A study of 213,383 cases from the California Cancer Registry. J. Clin. Gastroenterol. 41(2), 173–177 (2007).Article

Saltzstein,S.L。&Behling,C.A。年龄和时间是结直肠腺癌亚位点从左向右移动的因素:对来自加利福尼亚癌症登记处的213383例病例的研究。J、 临床。胃肠道。41(2),173-177(2007)。文章

PubMed

PubMed

Google Scholar

谷歌学者

Li, Y. et al. Prognostic effect of tumor sidedness in colorectal cancer: A SEER-based analysis. Clin. Colorectal Cancer. 18(1), e104–e116 (2019).Article

Li,Y.等。结直肠癌肿瘤侧性的预后影响:基于SEER的分析。临床。结直肠癌。18(1),e104–e116(2019)。文章

PubMed

PubMed

Google Scholar

谷歌学者

Faron, A. et al. Body composition analysis using CT and MRI: Intra-individual intermodal comparison of muscle mass and myosteatosis. Sci. Rep. 10(1), 11765 (2020).Article

Faron,A。等人。使用CT和MRI进行身体成分分析:肌肉质量和肌脂肪变性的个体内多式联运比较。科学。代表10(1),11765(2020)。文章

ADS

广告

CAS

中科院

PubMed

PubMed

PubMed Central

公共医学中心

Google Scholar

谷歌学者

Lortie, J. et al. The effect of computed tomography parameters on sarcopenia and myosteatosis assessment: A scoping review. J. Cachexia Sarcopenia Muscle. 13(6), 2807–2819 (2022).Article

Lortie,J.等人。计算机断层扫描参数对肌肉减少症和肌脂肪变性评估的影响:范围界定综述。J、 恶病质肌肉减少症。13(6),2807–2819(2022)。文章

PubMed

PubMed

PubMed Central

公共医学中心

Google Scholar

谷歌学者

Bloom, I., Shand, C., Cooper, C., Robinson, S. & Baird, J. Diet quality and sarcopenia in older adults: A systematic review. Nutrients. 10(3), 308 (2018).Article

Bloom,I.,Shand,C.,Cooper,C.,Robinson,S。&Baird,J。老年人的饮食质量和肌肉减少症:系统评价。营养素。10(3),308(2018)。文章

PubMed

PubMed

PubMed Central

公共医学中心

Google Scholar

谷歌学者

Gonzalez-Rocha, A., Mendez-Sanchez, L., Ortiz-Rodriguez, M. A. & Denova-Gutierrez, E. Effect of exercise on muscle mass, fat mass, bone mass, muscular strength and physical performance in community dwelling older adults: Systematic review and meta-analysis. Aging Dis. 13(5), 1421–1435 (2022).Article .

Gonzalez-Rocha,A.,Mendez-Sanchez,L.,Ortiz-Rodriguez,M.A。和Denova-Gutierrez,E。运动对社区老年人肌肉质量,脂肪质量,骨量,肌肉力量和身体表现的影响:系统评价和荟萃分析。老化Dis。13(5),1421-1435(2022)。文章。

PubMed

PubMed

PubMed Central

公共医学中心

Google Scholar

谷歌学者

Prokopidis, K. et al. Impact of probiotics on muscle mass, muscle strength and lean mass: A systematic review and meta-analysis of randomized controlled trials. J. Cachexia Sarcopenia Muscle. 14(1), 30–44 (2023).Article

Prokopidis,K。等人。益生菌对肌肉质量,肌肉力量和瘦体重的影响:随机对照试验的系统评价和荟萃分析。J、 恶病质肌肉减少症。14(1),30-44(2023)。文章

PubMed

PubMed

Google Scholar

谷歌学者

Stewart Coats, A. J. et al. Espindolol for the treatment and prevention of cachexia in patients with stage III/IV non-small cell lung cancer or colorectal cancer: A randomized, double-blind, placebo-controlled, international multicentre phase II study (the ACT-ONE trial). J. Cachexia Sarcopenia Muscle.

Stewart Coats,A.J.等人,Espindolol用于治疗和预防III/IV期非小细胞肺癌或结直肠癌患者的恶病质:一项随机,双盲,安慰剂对照,国际多中心II期研究(ACT-ONE试验)。J、 恶病质肌肉减少症。

7(3), 355–365 (2016).Article .

7(3),355-365(2016)。文章。

PubMed

PubMed

PubMed Central

公共医学中心

Google Scholar

谷歌学者

Download referencesAuthor informationAuthors and AffiliationsAcademic Unit of Surgery, University of Glasgow, Level 2, New Lister Building, Glasgow Royal Infirmary, Glasgow, G31 2ER, UKAllan M. Golder, Michael Ferguson, Paul McMillan, David Mansouri, Paul G. Horgan, Campbell S. Roxburgh, Ross D.

下载参考文献作者信息作者和附属机构格拉斯哥大学外科学系,2楼,新利斯特大楼,格拉斯哥皇家医院,格拉斯哥,G31 2ER,UKAllan M.Golder,Michael Ferguson,Paul McMillan,David Mansouri,Paul G.Horgan,Campbell S.Roxburgh,Ross D。

Dolan, Josh McGovern & Donald C. McMillanAuthorsAllan M. GolderView author publicationsYou can also search for this author in.

Dolan,Josh McGovern和Donald C.McMillanAuthorsAllan M.GolderView作者出版物您也可以在中搜索这位作者。

PubMed Google ScholarMichael FergusonView author publicationsYou can also search for this author in

PubMed Google Scholarmamichael FergusonView作者出版物您也可以在

PubMed Google ScholarPaul McMillanView author publicationsYou can also search for this author in

PubMed Google ScholarPaul McMillanView作者出版物您也可以在

PubMed Google ScholarDavid MansouriView author publicationsYou can also search for this author in

PubMed Google ScholarDavid MansouriView作者出版物您也可以在

PubMed Google ScholarPaul G. HorganView author publicationsYou can also search for this author in

PubMed Google ScholarPaul G.HorganView作者出版物您也可以在

PubMed Google ScholarCampbell S. RoxburghView author publicationsYou can also search for this author in

PubMed Google ScholarCampbell S.RoxburghView作者出版物您也可以在

PubMed Google ScholarRoss D. DolanView author publicationsYou can also search for this author in

PubMed Google ScholarRoss D.DolanView作者出版物您也可以在

PubMed Google ScholarJosh McGovernView author publicationsYou can also search for this author in

PubMed Google ScholarJosh McGovernView作者出版物您也可以在

PubMed Google ScholarDonald C. McMillanView author publicationsYou can also search for this author in

PubMed Google ScholarDonald C.McMillanView作者出版物您也可以在

PubMed Google ScholarContributionsAll authors have: Been involved in either designing, acquiring data or interpreting results for this study. Been involved in drafting or revising the manuscript. Approved the final version of this manuscript. Agreed to be accountable for this work.

PubMed谷歌学术贡献所有作者都参与了这项研究的设计,获取数据或解释结果。参与起草或修改稿件。批准了这份手稿的最终版本。同意对这项工作负责。

This has been approved by the Public Benefit and Privacy Panel (PBPP) for Scotland.Corresponding authorCorrespondence to.

这已获得苏格兰公共利益和隐私委员会(PBPP)的批准。对应作者对应。

Allan M. Golder.Ethics declarations

艾伦·M·戈尔德。道德宣言

Competing interests

相互竞争的利益

The authors declare no competing interests.

作者声明没有利益冲突。

Additional informationPublisher's noteSpringer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.Rights and permissions

Additional informationPublisher的noteSpringer Nature在已发布地图和机构隶属关系中的管辖权主张方面保持中立。权限和权限

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made.

开放获取本文是根据知识共享署名4.0国际许可证授权的,该许可证允许以任何媒体或格式使用,共享,改编,分发和复制,只要您对原始作者和来源给予适当的信任,提供知识共享许可证的链接,并指出是否进行了更改。

The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder.

本文中的图像或其他第三方材料包含在文章的知识共享许可中,除非在材料的信用额度中另有说明。如果材料未包含在文章的知识共享许可中,并且您的预期用途不受法律法规的许可或超出许可用途,则您需要直接获得版权所有者的许可。

To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/..

要查看此许可证的副本,请访问http://creativecommons.org/licenses/by/4.0/..

Reprints and permissionsAbout this articleCite this articleGolder, A.M., Ferguson, M., McMillan, P. et al. CT-derived body composition and differential association with age, TNM stage and systemic inflammation in patients with colon cancer.

转载和许可本文引用本文Golder,A.M.,Ferguson,M.,McMillan,P。等人。结肠癌患者CT衍生的身体成分以及与年龄,TNM分期和全身炎症的差异关联。

Sci Rep 14, 15673 (2024). https://doi.org/10.1038/s41598-024-65871-yDownload citationReceived: 25 October 2023Accepted: 25 June 2024Published: 08 July 2024DOI: https://doi.org/10.1038/s41598-024-65871-yShare this articleAnyone you share the following link with will be able to read this content:Get shareable linkSorry, a shareable link is not currently available for this article.Copy to clipboard.

Sci Rep 1415673(2024)。https://doi.org/10.1038/s41598-024-65871-yDownload引文收到日期:2023年10月25日接受日期:2024年6月25日发布日期:2024年7月8日OI:https://doi.org/10.1038/s41598-024-65871-yShare本文与您共享以下链接的任何人都可以阅读此内容:获取可共享链接对不起,本文目前没有可共享的链接。复制到剪贴板。

Provided by the Springer Nature SharedIt content-sharing initiative

由Springer Nature SharedIt内容共享计划提供

KeywordsAgeSarcopeniaBody compositionCTCancerColorectal

关键词sagesarcopeniabody compositionctcancercolorectal

Subjects

主题

BiomarkersCancer epidemiologyCancer imagingCancer metabolismColorectal cancerGastrointestinal cancer

生物标志物癌症流行病学癌症成像癌症代谢直肠癌胃肠道癌

CommentsBy submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.

评论通过提交评论,您同意遵守我们的条款和社区指南。如果您发现有虐待行为或不符合我们的条款或准则,请将其标记为不合适。